Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Griggs

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Communications|November 20, 2014
The immune synapse clears and excludes molecules above a size thresholdAdam N R Cartwright, Jeremy Griggs, Daniel M Davis
The American Journal of Pathology|March 14, 2002
Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4Jeremy Griggs, Jeremy N Skepper, Gerry A Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
CCR8<sup>+</sup>FOXp3<sup>+</sup> T<sub>reg</sub> cells as master drivers of immune regulationYiftah Barsheshet, Gizi Wildbaum, Eran Levy, et al.
Molecular Cancer Research : MCR|July 13, 2016
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor GrowthHeather Jackson, David Granger, Gavin Jones, et al.
Scientific Reports|September 9, 2017
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosisAndrew McBride, Anna M Hoy, Mark J Bamford, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Communications|November 20, 2014
The immune synapse clears and excludes molecules above a size thresholdAdam N R Cartwright, Jeremy Griggs, Daniel M Davis
The American Journal of Pathology|March 14, 2002
Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4Jeremy Griggs, Jeremy N Skepper, Gerry A Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
CCR8<sup>+</sup>FOXp3<sup>+</sup> T<sub>reg</sub> cells as master drivers of immune regulationYiftah Barsheshet, Gizi Wildbaum, Eran Levy, et al.
Molecular Cancer Research : MCR|July 13, 2016
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor GrowthHeather Jackson, David Granger, Gavin Jones, et al.
Scientific Reports|September 9, 2017
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosisAndrew McBride, Anna M Hoy, Mark J Bamford, et al.
Pageof 1